FDA Head To Talk Compounder Oversight In Meningitis Hearing
The head of the U.S. Food and Drug Administration will testify next week at the first congressional hearing on the meningitis outbreak that has claimed 30 lives, and will discuss the...To view the full article, register now.
Already a subscriber? Click here to view full article